United States · FDA National Drug Code directory

Rozlytrek

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
50242-623_b93e1fc0-614a-4e49-a91d-a409fb2db9f0
Product NDC
50242-623
Form
PELLET
Composition / generic term
ENTRECTINIB
Labeler
Genentech, Inc.
Marketing category
NDA
Marketing start / end (source format)
20231020
Source listing expiry
20261231

Source-listed ingredients

  • ENTRECTINIB — 50 mg/201

These values do not establish equivalence or a dose recommendation.

Packages

  • 42 DOSE PACK in 1 CARTON (50242-623-42) / 20 PELLET in 1 DOSE PACK (50242-623-01) · 50242-623-42

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →
Rozlytrek — United States | Molindra Medicines